Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The methods for handling missing data in clinical trials influence sample size requirements.

Guy-Robert Auleley1, Bruno Giraudeau, Gabriel Baron

  • 1Université Paris V-René Descartes, Faculté de Médecine Cochin Port-Royal and Clinique de Rhumatologie, Hôpital Cochin, AP-HP, Paris, France.

Journal of Clinical Epidemiology
|June 16, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-year impact on HPV vaccination coverage of a school- and primary care-based intervention: the PrevHPV cluster randomised trial.

Scientific reports·2026
Same author

Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.

The New England journal of medicine·2026
Same author

Completeness of reporting in abstracts of randomized controlled trials and factors associated with complete reporting: a meta-research study.

Research integrity and peer review·2026
Same author

Prevention of secondary infections by interferon-gamma in ICU-acquired sustained immune suppression in France: study protocol of the PLATINIUM randomised trial.

BMJ open·2026
Same author

Left ventricular global longitudinal strain impairment during long-term hydroxychloroquine exposure.

International journal of cardiology·2026
Same author

Consensus for the most suitable trial design to assess therapy for rare vascular malformations: a Delphi study.

Scientific reports·2026

Estimating sample sizes for osteoarthritis clinical trials requires careful consideration of missing data. Different methods for handling missing values significantly impact the required sample size for outcomes like joint space width and total hip arthroplasty.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Osteoarthritis Research

Background:

  • Missing data can significantly affect the reliability of osteoarthritis progression estimates in clinical studies.
  • Accurate sample size calculations are crucial for the successful design of disease-modifying osteoarthritis drug trials.

Purpose of the Study:

  • To evaluate the impact of various missing data handling methods on sample size estimations for hip osteoarthritis clinical trials.
  • To provide guidance on selecting primary outcomes and addressing missing data in trial planning.

Main Methods:

  • Utilized a two-parallel group design for hip osteoarthritis clinical trials.
  • Estimated sample sizes based on joint space width (JSW), JSW progression (JSN), time to total hip arthroplasty (THA), and a composite endpoint (JSN or THA).

Related Experiment Videos

  • Compared different approaches for managing missing data.

    • Main Results:

    • Three-year trials with 80% power and 50% treatment effect might need 121 patients for JSW and 57 for JSN using multiple imputation.
    • Sample sizes of 200 for THA and 47 for JSN or THA were also estimated.
    • Calculated sample sizes varied considerably based on the chosen missing data handling strategy.

    Conclusions:

    • The choice of missing data handling method critically influences sample size requirements in osteoarthritis trials.
    • Investigators should carefully select primary outcomes and pre-specify missing data procedures during clinical trial design.